Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Drugs
Drugs
Page 10 of 29
Health
A rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails
By
Naomi Kresge
and
Bloomberg
June 27, 2024
Baby boomers are abusing marijuana at a higher rate as more Medicare beneficiaries turn to cannabis with ‘little other safe choices for pain or sleep’
By
Lindsey Leake
June 25, 2024
Health
Novo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project
By
Naomi Kresge
and
Bloomberg
June 25, 2024
Finance
A 45-year-old Los Angeles man was charged in a $50 million scheme to launder Mexican cartel money via rich Chinese nationals who wanted luxury goods, prosecutors allege
By
Amanda Gerut
June 19, 2024
Health
Mold colonies and liquid-flooded air purifiers: CVS sourced medication from tainted factories—and it has twice the amount of recalls on store-brand drugs than competitors
By
Sasha Rogelberg
June 11, 2024
Politics
Biden’s plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say
By
Susan Jaffe
and
KFF Health News
June 11, 2024
Politics
Top assassin for the Sinaloa drug cartel, once described as ‘a complete psychopath’ with long history of gruesome acts, is extradited to U.S.
By
The Associated Press
May 25, 2024
Retail
Victory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit, but thousands still to come
By
Jef Feeley
,
Ashleigh Furlong
and
Bloomberg
May 24, 2024
Health
Weed beats booze as daily marijuana use outpaces drinking in definitive nationwide study of tens of millions of people
By
Carla K. Johnson
and
The Associated Press
May 22, 2024
Finance
Denmark’s economy shrinks 1.8% on reduced pharma production, showing extent of Novo Nordisk dependency
By
Sanne Wass
and
Bloomberg
May 21, 2024
Retail
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
By
Ashleigh Furlong
and
Bloomberg
May 21, 2024
Health
Justice Department formally moves to reclassify marijuana as a less dangerous drug in historic shift
By
The Associated Press
and
Lindsay Whitehurst
May 16, 2024
Companies
Employees are cheating on workplace drug tests at record rates—and legalized cannabis could be to blame
By
Christiaan Hetzner
May 15, 2024
What Medicare beneficiaries need to know about generic medications
By
Richard Eisenberg
May 15, 2024
Tech
Google DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology
By
Jeremy Kahn
May 8, 2024
Most Popular
North America
Gates Foundation plans to give away $9 billion in 2026 to prepare for the 2045 closure while slashing hundreds of jobs
By
Sydney Lake
Europe
Denmark offered to trade Greenland to the U.S. in 1910—and America thought it was crazy
By
Steven Lamy
and
The Conversation
Personal Finance
Sweden abolished its wealth tax 20 years ago. Then it became a 'paradise for the super-rich'
By
Miranda Sheild Johansson
and
The Conversation